Alitretinoin: a comprehensive review
Caleb Cheng(University of Michigan), Noah Scheinfeld(Columbia University), Jason Michaels(University of Nevada, Reno)
Cited by 86
Related Papers
Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy
|Proceedings of the National Academy of Sciences|2023|31
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13
|Cell Reports Medicine|2024|28
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer
|Proceedings of the National Academy of Sciences|2024|22
Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyve
|Journal of Medicinal Chemistry|2023|18